Please login to the form below
UK biotech funding falls 40% between 2018 and 2019
Drop attributed to global uncertainty and Neil Woodford scandal
Lilly will aim for one $1bn-$5bn deal per quarter in 2020
Company seeks to bolster pipeline with a string of M&A activity
Newly-listed BioNTech buys Neon to boost cell therapy assets
German biotech has agreed to pay $67m in the deal
Biogen just can’t quit Alzheimer’s, licensing another drug from Pfizer
Snaps up clinical-stage candidate for $75m upfront
Bayer bulks up in women’s health again with non-hormonal contraceptive deal
If approved candidate would become a first-in-category therapy
Lilly expands dermatology portfolio with $1.1bn Dermira deal
Deal includes FDA fast-tracked eczema drug
Bayer extends alliance with Evotec in women’s health
Five-year research agreement focuses on polycystic ovary syndrome
Almirall eyes $62m takeover of multicytokine specialist Bioniz
Gains clinical-stage drug for cutaneous T-cell lymphoma
Northsea Therapeutics raises $40m to develop fish oil NASH drug
Looking for mid-stage trial success in field littered with failures
Health coverage across state lines
Despite a total lack of legislative wins, the new administration has made its presence felt at home and abroad
-
Standing out in a crowdCelltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars
-
The diseased organisationLike humans, organisations can be afflicted by genetic disorders that hinder performance and threaten survival but these can be understood and cured
-
Novartis picks up inclisiran after completion of MedCo acquisitionIf approved could become blockbuster cholesterol treatment
-
EU, US biotechs merge to create fibrosis, cancer playerNew company will be headquartered in Copenhagen, Denmark
-
GSK divests travel vaccines to Bavarian Nordic as part of strategic refocusAgreed divestment deal is worth up to €955m
-
GSK, Pfizer and Sanofi among drugmakers planning price hikes in USPricing pressures increase amid intense political scrutiny
-
Astellas bulks up immuno-oncology pipeline with $665m Xyphos dealClosely follows $3bn acquistion of gene therapy specialist Audentes
-
J&J taps TARIS Biomedical for novel bladder cancer technologyTakes a bigger stake in the bladder cancer market
-
Roche pays $1.15bn for Sarepta’s Duchenne gene therapyPens another gene therapy deal following takeover of Spark Therapeutics
-
New hires at Ferring, Flexion and Immunocore The latest movers in pharma
-
New hires at Nanoform, Leo Pharma and CalliditasThe latest movers in pharma and biotech
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMOLatest movers in pharma and biotech
-
New hires at Mundipharma, Sinclair Pharma and Relay TherapeuticsLatest movers in pharma
-
Ipsen hires general manager, Laura Hamill joins Gilead and Orchard expands leadership teamThe latest industry movers
Latest sales appointments
Featured jobs
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Account Manager– Medical Communications
-
(Negotiable - depending on experience)
- Director of Scientific Services, Medical Communications, Six fig...
-
Six figure salary
-
Principal Medical Writer
-
£48 - 58, 000 according to skills and experience benefits
-
Consultant
-
competitive salary
- Account Director or Senior Account Director
-
Salary TBC
-
Vice President
-
Competitive Salary Offered
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
Subscribe to our email news alerts
- Moving annual total (MAT)
- Novo Nordisk gets MACE prevention claim for Ozempic in US
- NantKwest rockets on promising pancreatic cancer data
- Clovis leapfrogs PARP rivals, filing Rubraca for prostate cancer
- FDA delays decision on Intercept's NASH drug by three months
- Immuno-oncology, personalised medicine continues to drive pharma sector
PMHub
Red Health
Red Health was formed in 2007 to bring something fresh to the healthcare PR world. Our approach was simple –...
Latest intelligence
- White Paper for download - Explaining the price of your product
- In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
- OPEN Health expands offering with the launch of a new Learning & Development specialist team
- Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
- The changing nature of approvals – what does the future hold?
- The 2019 CMR International Pharmaceutical R&D Factbook...
Quick links
Infographics
